Drug Substance Analysis

November 2nd 2022

A thorough knowledge of both the upstream and downstream processes is required to ensure effective removal of residual impurities in biopharmaceuticals.

November 1st 2021

The need for improved analytics grows.

May 2nd 2021

Mass spectrometry and automation are growing in importance for protein characterization, but further improvements are still needed.

September 22nd 2020

Samsung will offer large-scale commercial manufacturing for drug substance and drug products to support AstraZeneca’s biologics therapeutics capabilities in the Asia-Pacific region.